You have 9 free searches left this month | for more free features.

Disease Progression

Showing 9976 - 10000 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

NonHodgkin's Lymphoma Refractory Trial in El Segundo (N803, CD19t-haNK suspension, Cyclophosphamide)

Not yet recruiting
  • NonHodgkin's Lymphoma Refractory
  • El Segundo, California
    CSSIFM
Nov 9, 2022

Hypophosphatasia Trial in Durham

Recruiting
  • Hypophosphatasia
    • Durham, North Carolina
      Duke University Medical Center
    Jan 27, 2022

    Relapsed or Refractory Multiple Myeloma Trial in United States (CAR2 Anti-CD38 A2 CAR-T Cells)

    Completed
    • Relapsed or Refractory Multiple Myeloma
    • CAR2 Anti-CD38 A2 CAR-T Cells
    • Jacksonville, Florida
    • +3 more
    Mar 14, 2022

    Batten Disease, Late-Infantile Neuronal Ceroid Lipofuscinosis Trial in New York (AAVrh.10CUhCLN2 vector 9.0x10^11 genome copies,

    Completed
    • Batten Disease
    • Late-Infantile Neuronal Ceroid Lipofuscinosis
    • AAVrh.10CUhCLN2 vector 9.0x10^11 genome copies
    • AAVrh.10CUhCLN2 vector 2.85x10^11 genome copies
    • New York, New York
      Weill Cornell Medical College
    Jan 31, 2021

    Stem Cells in NF1 Tumors of the Central Nervous System

    Suspended
    • Neurofibromatosis Type 1
    • Tumors of the Central Nervous System
    • Collection of Stem Cells
    • Washington, District of Columbia
      Children's National Medical Center
    Mar 8, 2022

    Metastatic Clear Cell Renal Cell Carcinoma Trial in Dallas (IL-2, Stereotactic Ablative Body Radiation Therapy)

    Completed
    • Metastatic Clear Cell Renal Cell Carcinoma
    • IL-2
    • Stereotactic Ablative Body Radiation Therapy
    • Dallas, Texas
      University of Texas Southwestern Medical Center
    Jul 28, 2021

    Muscular Atrophy, Spinal, Type II, Muscular Atrophy, Spinal, Type III Trial in France (Strength force measurment, Time tests,

    Not yet recruiting
    • Muscular Atrophy, Spinal, Type II
    • Muscular Atrophy, Spinal, Type III
    • Strength force measurment
    • +6 more
    • Angers, France
    • +5 more
    Apr 20, 2023

    Early Diagnosis of Type 1 Diabetes

    Recruiting
    • Type 1 Diabetes
      • Orlando, Florida
        AdventHealth Translational Research Institute
      Feb 15, 2022

      Lung Adenocarcinoma, Stage IV NSCLC, PD-1 Inhibitor Trial (Serplulimab and Bevacizumab injection)

      Not yet recruiting
      • Lung Adenocarcinoma
      • +3 more
      • Serplulimab and Bevacizumab injection
      • (no location specified)
      Dec 21, 2022

      Shear-wave Elastography Diffuse Liver Disease

      Not yet recruiting
      • Chronic Hepatic
      • Chronic Liver Disease and Cirrhosis
      • Shearwave elastography
      • (no location specified)
      Dec 17, 2021

      Metabolic Syndrome, Diabetes Trial in Amsterdam (6-BT, Placebo)

      Recruiting
      • Metabolic Syndrome
      • Diabetes Mellitus
      • 6-BT
      • Placebo
      • Amsterdam, Noord-Holland, Netherlands
        Amsterdam UMC
      Jul 25, 2023

      The Water Drinking Test in Glaucoma Study

      Recruiting
      • Glaucoma
      • Modified Diurnal Tension Curve
      • London, United Kingdom
        Imperial College Ophthalmic Research Group
      Mar 7, 2022

      Prostate Cancer Trial in Canada (Metformin, Placebo)

      Recruiting
      • Prostate Cancer
      • Winnipeg, Manitoba, Canada
      • +11 more
      Apr 16, 2021

      Secondary Angiosarcoma, Locally Advanced Sarcoma, Metastasis Trial in Nijmegen (Cemiplimab)

      Recruiting
      • Secondary Angiosarcoma
      • +2 more
      • Nijmegen, Netherlands
        RadboudUMC
      Jan 19, 2022

      Neurofibromatosis Type 1, Recurrent Childhood Brain Stem Glioma, Recurrent Childhood Visual Pathway Glioma Trial in United

      Completed
      • Neurofibromatosis Type 1
      • +4 more
      • Laboratory Biomarker Analysis
      • +2 more
      • Los Angeles, California
      • +11 more
      Apr 22, 2022

      Metastatic Malignant Tumor in the Adult Brain, Primary Brain Tumor Trial in Duarte (procedure, drug, other)

      Active, not recruiting
      • Metastatic Malignant Neoplasm in the Adult Brain
      • Primary Brain Tumor
      • Therapeutic Conventional Surgery
      • +4 more
      • Duarte, California
        City of Hope Medical Center
      Mar 16, 2022

      Arterial Calcifications in Nocturnal Hemodialysis and Renal

      Completed
      • Kidney Disease
        • Utrecht, Netherlands
        • +1 more
        Dec 17, 2018

        Nasopharyngeal Carcinoma Trial in Guangzhou (Induction chemo plus Concurrent chemo, Concurrent chemo, IMRT)

        Not yet recruiting
        • Nasopharyngeal Carcinoma
        • Induction chemotherapy plus Concurrent chemotherapy
        • +2 more
        • Guangzhou, Guangdong, China
          Sun Yat-sen University Cancer Center
        Nov 17, 2022

        Advanced NSCLC Trial in Yangzhou (camrelizumab + famitinib, famitinib, docetaxel)

        Recruiting
        • Advanced NSCLC
        • camrelizumab + famitinib
        • +2 more
        • Yangzhou, Jiangsu, China
          Subei People's Hospital of Jiangsu Province
        Jan 11, 2022

        Metastatic Urothelial Carcinoma Trial in Tampa, Boston (Ipilimumab, Nivolumab, Sacituzumab govitecan)

        Recruiting
        • Metastatic Urothelial Carcinoma
        • Tampa, Florida
          Moffitt Cancer Center
        Jan 24, 2023

        Hematological Malignancies Trial in Worldwide (Teclistamab)

        Recruiting
        • Hematological Malignancies
        • Birmingham, Alabama
        • +80 more
        Jan 27, 2023

        Advanced Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma, Metastatic Head-and-neck

        Recruiting
        • Advanced Head and Neck Squamous Cell Carcinoma
        • +5 more
        • Pembrolizumab (immunotherapy)
        • Quad-shot palliative radiotherapy
        • Winston-Salem, North Carolina
          Wake Forest Baptist Comprehensive Cancer Center
        Feb 7, 2022

        Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma Trial in Shanghai (Dalpiciclib+cetuximab)

        Recruiting
        • Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
        • Shanghai, Shanghai, China
          the Ninth People's Hospital Affiliated to Shanghai Jiao Tong Uni
        Feb 9, 2023

        Recurrent NSCLC Trial in Sacramento, San Francisco (INC280, erlotinib HCl)

        Completed
        • Recurrent Non-small Cell Lung Cancer
        • Sacramento, California
        • +1 more
        Oct 11, 2021

        Solid Tumour Trial in United States (Capivasertib, Midazolam)

        Recruiting
        • Solid Tumour
        • West Hollywood, California
        • +9 more
        Aug 22, 2022